Condition: Renal Cell Carcinoma (RCC)

Study Type: Interventional

Clinical Trials Identifier NCT 8-digits: NCT07038733

Sponsor: Yale University

Eligibility:

• Age: minimum 18 Years maximum N/A
• Gender: All

Inclusion Criteria:

1. Candidates for inclusion include adult patients with either a known or suspected kidney cancer referred to Yale Genitourinary Oncology providers in the Yale Urology, Medical Oncology and Radiation Oncology or Nephrology Departments. These individuals will be receiving clinical evaluation/medical treatment/surgery/procedures at Yale New Haven Hospital or the Smilow Cancer Hospital. Participant eligibility will be determined by study investigators and will be offered protocol details. Interested participants will be invited to participate by study investigators. Consent will be obtained by study investigators or other authorized study personnel. Any potential adult participants with known or suspected kidney cancers with a renal mass who are patients of non-study physicians will be invited to participate by study personal only with the approval of their treating physician.

Exclusion Criteria:

• Participants under the age of 18. Children will not be enrolled on the study.
• Participants known to be pregnant or actively breastfeeding.
• Iodine allergy hypersensitivity.

View trial on ClinicalTrials.gov